SENS Research Foundation is a 501(c)(3) public charity that is transforming the way the world researches and treats age-related disease.
SENS Research Foundation (SRF) was founded in 2009.
SENS Research Foundation is primarily funded by grants from various foundations and non-profit organizations and through the generosity of philanthropic donors.
2013 Budget: US$4.5 million
2012 Expenditures: US$3 million
Active extramural research grants: 14
Active intramural research projects: 3
What Makes Our Approach Different
Cellular and molecular damage gradually accumulates in the body as a byproduct of metabolism, and this damage is ultimately responsible for the pathology of aging. The great majority of existing treatments for age-related diseases either alter metabolism to prevent the accumulation of damage, or attempt to modulate the damage’s downstream effects. SENS Research Foundation is working to lay the groundwork for new therapies that instead target and repair this damage. These treatments, which apply techniques from regenerative medicine to the damage of aging, are known as rejuvenation biotechnologies.
What We Do
We perform the following activities to advance our mission:
- We fund scientific research at some of the world's most prestigious universities and institutes.
- We conduct research of our own at the SENS Research Foundation Research Center in Mountain View, California.
- We guide the next generation of researchers focused on the development of rejuvenation biotechnologies through our student program, SRF Education. SRF Education awards grants to promising university students, operates a summer internship program, and is developing open online coursework.
- We conduct outreach and connect individuals and organizations to help create and expand the rejuvenation biotechnology field.
- We host conferences to bring some of the world’s most capable scientists together in one room to discuss the future of medicine.
Profiles of Key Staff
Michael Kope, Chief Executive Officer
Mr. Kope received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel; as Director of Corporate Development for Aviron and for Medimmune, Inc., and as CEO and officer of a number of start-ups in the biotechnology space.
Aubrey de Grey, Chief Science Officer
Dr. de Grey received his Ph.D. in Biology from the University of Cambridge, and has been a prominent member of the biogerontology research community since the 1990s. He pioneered the idea of applying the techniques of regenerative medicine and related fields to prevent the ill-health of old age, which underpins SRF’s research agenda. Dr. de Grey is a Fellow of the Gerontological Society of America and the American Aging Association, and is editor-in-chief of the journal Rejuvenation Research.
Research Advisory Board
Our Research Advisory Board has 25 members, all of whom are leaders in fields relevant to SRF's research agenda, such as regenerative medicine and gerontology. These advisors stand behind SRF’s mission and assist the organization by helping to determine the course of its research.